Detalhe da pesquisa
1.
Tumour 63 protein (p63) in breast pathology: biology, immunohistochemistry, diagnostic applications, and pitfalls.
Histopathology
; 84(5): 723-741, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38012539
2.
Dataset for reporting of the invasive carcinoma of the breast: recommendations from the International Collaboration on Cancer Reporting (ICCR).
Histopathology
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38719547
3.
A dedicated structured data set for reporting of invasive carcinoma of the breast in the setting of neoadjuvant therapy: recommendations from the International Collaboration on Cancer Reporting (ICCR).
Histopathology
; 84(7): 1111-1129, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38443320
4.
Prognostic significance of microinvasion with ductal carcinoma in situ of the breast: a meta-analysis.
Breast Cancer Res Treat
; 197(2): 245-254, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36427119
5.
Pitfalls in breast pathology.
Histopathology
; 82(1): 140-161, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36482276
6.
An update on the pathological classification of breast cancer.
Histopathology
; 82(1): 5-16, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36482272
7.
Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast Cancer.
Clin Chem
; 68(6): 837-847, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35312747
8.
Nuclear morphology in breast lesions: refining its assessment to improve diagnostic concordance.
Histopathology
; 80(3): 515-528, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34605058
9.
The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry-equivocal invasive breast cancer.
Histopathology
; 81(4): 511-519, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35879836
10.
Assessment of Predictive Biomarkers in Breast Cancer: Challenges and Updates.
Pathobiology
; 89(5): 263-277, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35728576
11.
Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) cases.
Br J Cancer
; 124(11): 1836-1842, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33762723
12.
Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative.
Br J Cancer
; 124(9): 1503-1512, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33597715
13.
Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer.
Mod Pathol
; 34(7): 1271-1281, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33526875
14.
Adenomyoepithelioma of the breast: a proposal for classification.
Histopathology
; 79(4): 465-479, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33829532
15.
Metaplastic carcinomas of the breast without evidence of epithelial differentiation: a diagnostic approach for management.
Histopathology
; 78(5): 759-771, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33113154
16.
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.
J Pathol
; 250(5): 667-684, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32129476
17.
Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines.
Ann Intern Med
; 172(1): 46-56, 2020 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31766052
18.
Whole-exome sequencing of long-term, never relapse exceptional responders of trastuzumab-treated HER2+ metastatic breast cancer.
Br J Cancer
; 123(8): 1219-1222, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32713940
19.
Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study.
Breast Cancer Res Treat
; 183(3): 759-770, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32734520
20.
Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators.
BMC Cancer
; 20(1): 795, 2020 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32831048